A new PI3K/mTOR inhibitor (GDC-0084) dramatically inhibits the proliferation of glioblastoma cells in in vitro and effectively inhibits the growth of U87 MG glioblastoma in tumor-bearing mice via lowering AKT phosphorylation [154]. This evidence concerns the gene MTOR and glioblastoma.